Cancer gene discovery in mouse and man

Jenny Mattison1, Louise van der Weyden1, Tim Hubbard1, David J. Adams1
1Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1HH, UK

Tài liệu tham khảo

Davies, 2002, Mutations of the BRAF gene in human cancer, Nature, 417, 949, 10.1038/nature00766 Bardelli, 2003, Mutational analysis of the tyrosine kinome in colorectal cancers, Science, 300, 949, 10.1126/science.1082596 Wang, 2004, Mutational analysis of the tyrosine phosphatome in colorectal cancers, Science, 304, 1164, 10.1126/science.1096096 Samuels, 2004, Oncogenic mutations of PIK3CA in human cancers, Cell. Cycle., 3, 1221, 10.4161/cc.3.10.1164 Bachman, 2004, The PIK3CA gene is mutated with high frequency in human breast cancers, Cancer Biol. Ther., 3, 772, 10.4161/cbt.3.8.994 Campbell, 2004, Mutation of the PIK3CA gene in ovarian and breast cancer, Cancer Res., 64, 7678, 10.1158/0008-5472.CAN-04-2933 Levine, 2005, Frequent mutation of the PIK3CA gene in ovarian and breast cancers, Clin. Cancer Res., 11, 2875, 10.1158/1078-0432.CCR-04-2142 Parsons, 2005, Colorectal cancer: mutations in a signalling pathway, Nature, 436, 792, 10.1038/436792a Brugge, 2007, A new mutational AKTivation in the PI3K pathway, Cancer Cell., 12, 104, 10.1016/j.ccr.2007.07.014 Stephens, 2005, A screen of the complete protein kinase gene family identifies diverse patterns of somatic mutations in human breast cancer, Nat. Genet., 37, 590, 10.1038/ng1571 Davies, 2005, Somatic mutations of the protein kinase gene family in human lung cancer, Cancer Res., 65, 7591, 10.1158/0008-5472.CAN-05-1855 Greenman, 2007, Patterns of somatic mutation in human cancer genomes, Nature, 446, 153, 10.1038/nature05610 Sjoblom, 2006, The consensus coding sequences of human breast and colorectal cancers, Science, 314, 268, 10.1126/science.1133427 Lin, 2007, A multidimensional analysis of genes mutated in breast and colorectal cancers, Genome Res., 17, 1304, 10.1101/gr.6431107 Getz, 2007, Comment on “The consensus coding sequences of human breast and colorectal cancers”, Science, 317, 1500, 10.1126/science.1138764 Kaiser, 2006, Cancer. First pass at cancer genome reveals complex landscape, Science, 313, 1370, 10.1126/science.313.5792.1370 Pruitt, 2007, NCBI reference sequences (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins, Nucleic Acids Res., 35, D61, 10.1093/nar/gkl842 Wood, 2007, The genomic landscapes of human breast and colorectal cancers, Science, 318, 1108, 10.1126/science.1145720 Frohling, 2007, Identification of driver and passenger mutations of FLT3 by high-throughput DNA sequence analysis and functional assessment of candidate alleles, Cancer Cell., 12, 501, 10.1016/j.ccr.2007.11.005 Futreal, 2007, Backseat drivers take the wheel, Cancer Cell., 12, 493, 10.1016/j.ccr.2007.11.020 Forbes, 2006, Cosmic 2005, Br. J. Cancer, 94, 318, 10.1038/sj.bjc.6602928 Hodges, 2007, Genome-wide in situ exon capture for selective resequencing, Nat. Genet., 39, 1522, 10.1038/ng.2007.42 Bhattacharjee, 2001, Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses, Proc. Natl. Acad. Sci. U. S. A., 98, 13790, 10.1073/pnas.191502998 Garber, 2001, Diversity of gene expression in adenocarcinoma of the lung, Proc. Natl. Acad. Sci. U. S. A., 98, 13784, 10.1073/pnas.241500798 Beer, 2002, Gene-expression profiles predict survival of patients with lung adenocarcinoma, Nat. Med., 8, 816, 10.1038/nm733 Sweet-Cordero, 2005, An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis, Nat. Genet., 37, 48, 10.1038/ng1490 Eden, 2004, “Good Old” clinical markers have similar power in breast cancer prognosis as microarray gene expression profilers, Eur. J. Cancer, 40, 1837, 10.1016/j.ejca.2004.02.025 Wang, 2009, RNA-Seq: a revolutionary tool for transcriptomics, Nat. Rev. Genet., 10, 57, 10.1038/nrg2484 Feuk, 2006, Structural variation in the human genome, Nat. Rev. Genet., 7, 85, 10.1038/nrg1767 Redon, 2006, Global variation in copy number in the human genome, Nature, 444, 444, 10.1038/nature05329 Stranger, 2007, Relative impact of nucleotide and copy number variation on gene expression phenotypes, Science, 315, 848, 10.1126/science.1136678 Lengauer, 1998, Genetic instabilities in human cancers, Nature, 396, 643, 10.1038/25292 Fridlyand, 2006, Breast tumor copy number aberration phenotypes and genomic instability, BMC Cancer, 6, 96, 10.1186/1471-2407-6-96 Hernando, 2004, Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control, Nature, 430, 797, 10.1038/nature02820 Albertson, 2003, Chromosome aberrations in solid tumors, Nat. Genet., 34, 369, 10.1038/ng1215 Li, 2009, Cancer-causing karyotypes: chromosomal equilibria between destabilizing aneuploidy and stabilizing selection for oncogenic function, Cancer Genet. Cytogenet., 188, 1, 10.1016/j.cancergencyto.2008.08.016 Kallioniemi, 1992, Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors, Science, 258, 818, 10.1126/science.1359641 Pinkel, 1998, High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays, Nat. Genet., 20, 207, 10.1038/2524 Knutsen, 2005, The interactive online SKY/M-FISH and CGH database and the Entrez cancer chromosomes search database: linkage of chromosomal aberrations with the genome sequence, Genes Chromosomes Cancer, 44, 52, 10.1002/gcc.20224 Pollack, 1999, Genome-wide analysis of DNA copy-number changes using cDNA microarrays, Nat. Genet., 23, 41, 10.1038/14385 Albertson, 2003, Genomic microarrays in human genetic disease and cancer, Hum. Mol. Genet., 2, R145, 10.1093/hmg/ddg261 Thomas, 2006, Genomic approaches to lung cancer, Clin. Cancer Res., 12, 4384s, 10.1158/1078-0432.CCR-06-0098 Kennedy, 2003, Large-scale genotyping of complex DNA, Nat. Biotechnol., 21, 1233, 10.1038/nbt869 Matsuzaki, 2004, Genotyping over 100,000 SNPs on a pair of oligonucleotide arrays, Nat. Methods, 1, 109, 10.1038/nmeth718 Bignell, 2004, High-resolution analysis of DNA copy number using oligonucleotide microarrays, Genome Res., 14, 287, 10.1101/gr.2012304 Xiao, 2007, A multi-array multi-SNP genotyping algorithm for Affymetrix SNP microarrays, Bioinformatics, 23, 1459, 10.1093/bioinformatics/btm131 Zhao, 2004, An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays, Cancer Res., 64, 3060, 10.1158/0008-5472.CAN-03-3308 Raghavan, 2005, Genome-wide single nucleotide polymorphism analysis reveals frequent partial uniparental disomy due to somatic recombination in acute myeloid leukemias, Cancer Res., 65, 375, 10.1158/0008-5472.375.65.2 Calhoun, 2006, Copy-number methods dramatically underestimate loss of heterozygosity in cancer, Genes Chromosomes Cancer, 45, 1070, 10.1002/gcc.20365 Kloth, 2007, Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer, BMC Genomics, 8, 53, 10.1186/1471-2164-8-53 Quackenbush, 2002, Microarray data normalization and transformation, Nat. Genet., 32 Suppl., 496, 10.1038/ng1032 Neuvial, 2006, Spatial normalization of array-CGH data, BMC Bioinformatics, 7, 264, 10.1186/1471-2105-7-264 Khojasteh, 2005, A stepwise framework for the normalization of array CGH data, BMC Bioinformatics, 6, 274, 10.1186/1471-2105-6-274 Staaf, 2007, Normalization of array-CGH data: influence of copy number imbalances, BMC Genomics, 8, 382, 10.1186/1471-2164-8-382 Marioni, 2007, Breaking the waves: improved detection of copy number variation from microarray-based comparative genomic hybridization, Genome Biol., 8, R228, 10.1186/gb-2007-8-10-r228 Nannya, 2005, A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays, Cancer Res., 65, 6071, 10.1158/0008-5472.CAN-05-0465 Huang, 2004, Whole genome DNA copy number changes identified by high density oligonucleotide arrays, Hum. Genomics, 1, 287, 10.1186/1479-7364-1-4-287 Baross, 2007, Assessment of algorithms for high throughput detection of genomic copy number variation in oligonucleotide microarray data, BMC Bioinformatics, 8, 368, 10.1186/1471-2105-8-368 Rigaill, 2008, ITALICS: an algorithm for normalization and DNA copy number calling for Affymetrix SNP arrays, Bioinformatics, 24, 768, 10.1093/bioinformatics/btn048 Hupe, 2004, Analysis of array CGH data: from signal ratio to gain and loss of DNA regions, Bioinformatics, 20, 3413, 10.1093/bioinformatics/bth418 Olshen, 2004, Circular binary segmentation for the analysis of array-based DNA copy number data, Biostatistics, 5, 557, 10.1093/biostatistics/kxh008 Venkatraman, 2007, A faster circular binary segmentation algorithm for the analysis of array CGH data, Bioinformatics, 23, 657, 10.1093/bioinformatics/btl646 Marioni, 2006, BioHMM: a heterogeneous hidden Markov model for segmenting array CGH data, Bioinformatics, 22, 1144, 10.1093/bioinformatics/btl089 Rueda, 2007, Flexible and accurate detection of genomic copy-number changes from aCGH, PLoS Comput. Biol., 3, e122, 10.1371/journal.pcbi.0030122 Shah, 2006, Integrating copy number polymorphisms into array CGH analysis using a robust HMM, Bioinformatics, 22, e431, 10.1093/bioinformatics/btl238 Stjernqvist, 2007, Continuous-index hidden Markov modelling of array CGH copy number data, Bioinformatics, 23, 1006, 10.1093/bioinformatics/btm059 Engler, 2006, A pseudolikelihood approach for simultaneous analysis of array comparative genomic hybridizations, Biostatistics, 7, 399, 10.1093/biostatistics/kxj015 Wang, 2005, A method for calling gains and losses in array CGH data, Biostatistics, 6, 45, 10.1093/biostatistics/kxh017 Hsu, 2005, Denoising array-based comparative genomic hybridization data using wavelets, Biostatistics, 6, 211, 10.1093/biostatistics/kxi004 Huang, 2007, Robust smooth segmentation approach for array CGH data analysis, Bioinformatics, 23, 2463, 10.1093/bioinformatics/btm359 Diaz-Uriarte, 2007, ADaCGH: a parallelized web-based application and R package for the analysis of aCGH data, PLoS ONE, 2, e737, 10.1371/journal.pone.0000737 Lai, 2008, CGHweb: a tool for comparing DNA copy number segmentations from multiple algorithms, Bioinformatics, 24, 1014, 10.1093/bioinformatics/btn067 Yu, 2007, A forward-backward fragment assembling algorithm for the identification of genomic amplification and deletion breakpoints using high-density single nucleotide polymorphism (SNP) array, BMC Bioinformatics, 8, 145, 10.1186/1471-2105-8-145 Huang, 2006, CARAT: a novel method for allelic detection of DNA copy number changes using high density oligonucleotide arrays, BMC Bioinformatics, 7, 83, 10.1186/1471-2105-7-83 Lamy, 2007, A Hidden Markov Model to estimate population mixture and allelic copy-numbers in cancers using Affymetrix SNP arrays, BMC Bioinformatics, 8, 434, 10.1186/1471-2105-8-434 LaFramboise, 2005, Allele-specific amplification in cancer revealed by SNP array analysis, PLoS Comput. Biol., 1, e65, 10.1371/journal.pcbi.0010065 Rouveirol, 2006, Computation of recurrent minimal genomic alterations from array-CGH data, Bioinformatics, 22, 849, 10.1093/bioinformatics/btl004 Diskin, 2006, STAC: a method for testing the significance of DNA copy number aberrations across multiple array-CGH experiments, Genome Res., 16, 1149, 10.1101/gr.5076506 Fiegler, 2007, High resolution array-CGH analysis of single cells, Nucleic Acids Res., 35, e15, 10.1093/nar/gkl1030 Klijn, 2008, Identification of cancer genes using a statistical framework for multiexperiment analysis of nondiscretized array CGH data, Nucleic Acids Res., 36, e13, 10.1093/nar/gkm1143 Bignell, 2007, Architectures of somatic genomic rearrangement in human cancer amplicons at sequence-level resolution, Genome Res., 17, 1296, 10.1101/gr.6522707 Schwab, 1999, Oncogene amplification in solid tumors, Semin. Cancer Biol., 9, 319, 10.1006/scbi.1999.0126 Seeger, 1985, Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas, N. Engl. J. Med., 313, 1111, 10.1056/NEJM198510313131802 Cobleigh, 1999, Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease, J. Clin. Oncol., 17, 2639, 10.1200/JCO.1999.17.9.2639 Li, 1997, PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer, Science, 275, 1943, 10.1126/science.275.5308.1943 Orlow, 1995, Deletion of the p16 and p15 genes in human bladder tumors, J. Natl. Cancer Inst., 87, 1524, 10.1093/jnci/87.20.1524 Cox, 2005, A survey of homozygous deletions in human cancer genomes, Proc. Natl. Acad. Sci. U. S. A., 102, 4542, 10.1073/pnas.0408593102 Futreal, 2004, A census of human cancer genes, Nat. Rev. Cancer, 4, 177, 10.1038/nrc1299 Maher, 2006, Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities, Cancer Res., 66, 11502, 10.1158/0008-5472.CAN-06-2072 Meza-Zepeda, 2006, Array comparative genomic hybridization reveals distinct DNA copy number differences between gastrointestinal stromal tumors and leiomyosarcomas, Cancer Res., 66, 8984, 10.1158/0008-5472.CAN-06-1972 Chin, 2006, Genomic and transcriptional aberrations linked to breast cancer pathophysiologies, Cancer Cell., 10, 529, 10.1016/j.ccr.2006.10.009 Hicks, 2006, Novel patterns of genome rearrangement and their association with survival in breast cancer, Genome Res., 16, 1465, 10.1101/gr.5460106 Kersemaekers, 1998, Allelic loss and prognosis in carcinoma of the uterine cervix, Int. J. Cancer, 79, 411, 10.1002/(SICI)1097-0215(19980821)79:4<411::AID-IJC17>3.0.CO;2-7 Bernardini, 2005, High-resolution mapping of genomic imbalance and identification of gene expression profiles associated with differential chemotherapy response in serous epithelial ovarian cancer, Neoplasia, 7, 603, 10.1593/neo.04760 Kim, 2007, Analysis of chromosomal changes in serous ovarian carcinoma using high-resolution array comparative genomic hybridization: potential predictive markers of chemoresistant disease, Genes Chromosomes Cancer, 46, 1, 10.1002/gcc.20384 Garraway, 2006, From integrated genomics to tumor lineage dependency, Cancer Res., 66, 2506, 10.1158/0008-5472.CAN-05-4604 Garraway, 2005, Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma, Nature, 436, 117, 10.1038/nature03664 Weir, 2007, Characterizing the cancer genome in lung adenocarcinoma, Nature, 450, 893, 10.1038/nature06358 Kendall, 2007, Oncogenic cooperation and coamplification of developmental transcription factor genes in lung cancer, Proc. Natl. Acad. Sci. U. S. A., 104, 16663, 10.1073/pnas.0708286104 Veltman, 2003, Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors, Cancer Res., 63, 2872 Albertson, 2000, Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene, Nat. Genet., 25, 144, 10.1038/75985 Lilljebjorn, 2007, Leukemia, 21, 2137, 10.1038/sj.leu.2404879 Hyman, 2002, Impact of DNA amplification on gene expression patterns in breast cancer, Cancer Res., 62, 6240 Pollack, 2002, Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors, Proc. Natl. Acad. Sci. U. S. A., 99, 12963, 10.1073/pnas.162471999 Mullighan, 2007, Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia, Nature, 446, 758, 10.1038/nature05690 Wang, 2007, Genome-wide SNP analysis in cancer: leukemia shows the way, Cancer Cell., 11, 308, 10.1016/j.ccr.2007.03.017 Watson, 2007, Cytogenetically balanced translocations are associated with focal copy number alterations, Hum. Genet., 120, 795, 10.1007/s00439-006-0251-9 Pinkel, 2005, Comparative genomic hybridization, Annu. Rev. Genomics Hum. Genet., 6, 331, 10.1146/annurev.genom.6.080604.162140 Mitelman, 2004, Fusion genes and rearranged genes as a linear function of chromosome aberrations in cancer, Nat. Genet., 36, 331, 10.1038/ng1335 Volik, 2006, Decoding the fine-scale structure of a breast cancer genome and transcriptome, Genome Res., 16, 394, 10.1101/gr.4247306 Howarth, 2008, Array painting reveals a high frequency of balanced translocations in breast cancer cell lines that break in cancer-relevant genes, Oncogene, 27, 3345, 10.1038/sj.onc.1210993 Tomlins, 2005, Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer, Science, 310, 644, 10.1126/science.1117679 Soda, 2007, Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer, Nature, 448, 561, 10.1038/nature05945 Volik, 2003, End-sequence profiling: sequence-based analysis of aberrant genomes, Proc. Natl. Acad. Sci. U. S. A., 100, 7696, 10.1073/pnas.1232418100 Campbell, 2008, Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing, Nat. Genet., 40, 722, 10.1038/ng.128 McClintock, 1941, The stability of broken ends of chromosomes in Zea Mays, Genetics, 26, 234, 10.1093/genetics/26.2.234 Raphael, 2008, A sequence-based survey of the complex structural organization of tumor genomes, Genome Biol., 9, R59, 10.1186/gb-2008-9-3-r59 Bashir, 2008, Evaluation of paired-end sequencing strategies for detection of genome rearrangements in cancer, PLoS Comput. Biol., 4, e1000051, 10.1371/journal.pcbi.1000051 Bentley, 2008, Accurate whole human genome sequencing using reversible terminator chemistry, Nature, 456, 53, 10.1038/nature07517 Wang, 2008, The diploid genome sequence of an Asian individual, Nature, 456, 60, 10.1038/nature07484 Ley, 2008, DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome, Nature, 456, 66, 10.1038/nature07485 Pelengaris, 2006 Merlo, 1995, 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers, Nat. Med., 1, 686, 10.1038/nm0795-686 Herman, 1995, Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers, Cancer Res., 55, 4525 Herman, 1994, Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma, Proc. Natl. Acad. Sci. U. S. A., 91, 9700, 10.1073/pnas.91.21.9700 Esteller, 2000, Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors, J. Natl. Cancer Inst., 92, 564, 10.1093/jnci/92.7.564 Jones, 2002, The fundamental role of epigenetic events in cancer, Nat. Rev. Genet., 3, 415, 10.1038/nrg816 Frigola, 2006, Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band, Nat. Genet., 38, 540, 10.1038/ng1781 Toyota, 1999, CpG island methylator phenotype in colorectal cancer, Proc. Natl. Acad. Sci. U. S. A., 96, 8681, 10.1073/pnas.96.15.8681 Weisenberger, 2006, CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer, Nat. Genet., 38, 787, 10.1038/ng1834 Widschwendter, 2007, Epigenetic stem cell signature in cancer, Nat. Genet., 39, 157, 10.1038/ng1941 Callinan, 2006, The emerging science of epigenomics, Hum. Mol. Genet., 1, R95, 10.1093/hmg/ddl095 Jones, 2007, The epigenomics of cancer, Cell, 128, 683, 10.1016/j.cell.2007.01.029 Ruprecht, 2008, Endogenous retroviruses and cancer, Cell. Mol. Life Sci., 65, 3366, 10.1007/s00018-008-8496-1 Deichmann, 2007, Vector integration is nonrandom and clustered and influences the fate of lymphopoiesis in SCID-X1 gene therapy, J. Clin. Invest., 117, 2225, 10.1172/JCI31659 Hacein-Bey-Abina, 2008, Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1, J. Clin. Invest., 118, 3132, 10.1172/JCI35700 Wang, 2008, DNA bar coding and pyrosequencing to analyze adverse events in therapeutic gene transfer, Nucleic Acids Res., 36, e49, 10.1093/nar/gkn125 Howe, 2008, Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients, J. Clin. Invest., 118, 3143, 10.1172/JCI35798 Pujana, 2007, Network modeling links breast cancer susceptibility and centrosome dysfunction, Nat. Genet., 39, 1338, 10.1038/ng.2007.2 Wong, 2008, Module map of stem cell genes guides creation of epithelial cancer stem cells, Cell Stem Cell, 2, 333, 10.1016/j.stem.2008.02.009 Ben-Porath, 2008, An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors, Nat. Genet., 40, 499, 10.1038/ng.127 Jonsson, 2006, Cluster analysis of networks generated through homology: automatic identification of important protein communities involved in cancer metastasis, BMC Bioinformatics, 7, 2, 10.1186/1471-2105-7-2 Frese, 2007, Maximizing mouse cancer models, Nat. Rev. Cancer, 7, 645, 10.1038/nrc2192 Sharpless, 2006, The mighty mouse: genetically engineered mouse models in cancer drug development, Nat. Rev. Drug Discov., 5, 741, 10.1038/nrd2110 Baron, 2000, Tet repressor-based system for regulated gene expression in eukaryotic cells: principles and advances, Methods Enzymol., 327, 401, 10.1016/S0076-6879(00)27292-3 Eilers, 1989, Chimaeras of myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells, Nature, 340, 66, 10.1038/340066a0 Muller, 1999, Ten years of gene targeting: targeted mouse mutants, from vector design to phenotype analysis, Mech. Dev., 82, 3, 10.1016/S0925-4773(99)00021-0 Stewart, 1984, Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes, Cell, 38, 627, 10.1016/0092-8674(84)90257-5 Adams, 1985, The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice, Nature, 318, 533, 10.1038/318533a0 Bottinger, 1997, Transgenic mice overexpressing a dominant-negative mutant type II transforming growth factor beta receptor show enhanced tumorigenesis in the mammary gland and lung in response to the carcinogen 7,12-dimethylbenz-[a]-anthracene, Cancer Res., 57, 5564 Robertson, 1986, Germ-line transmission of genes introduced into cultured pluripotential cells by retroviral vector, Nature, 323, 445, 10.1038/323445a0 Sauer, 1988, Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1, Proc. Natl. Acad. Sci. U. S. A., 85, 5166, 10.1073/pnas.85.14.5166 Lakso, 1992, Targeted oncogene activation by site-specific recombination in transgenic mice, Proc. Natl. Acad. Sci. U. S. A., 89, 6232, 10.1073/pnas.89.14.6232 Smith, 2002, Cre-loxP chromosome engineering of a targeted deletion in the mouse corresponding to the 3p21.3 region of homozygous loss in human tumours, Oncogene, 21, 4521, 10.1038/sj.onc.1205530 Kmita, 2000, Targeted inversion of a polar silencer within the HoxD complex re-allocates domains of enhancer sharing, Nat. Genet., 26, 451, 10.1038/82593 Forster, 2003, Engineering de novo reciprocal chromosomal translocations associated with Mll to replicate primary events of human cancer, Cancer Cell., 3, 449, 10.1016/S1535-6108(03)00106-5 de Alboran, 2001, Analysis of C-MYC function in normal cells via conditional gene-targeted mutation, Immunity, 14, 45, 10.1016/S1074-7613(01)00088-7 Jackson, 2001, Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras, Genes Dev., 15, 3243, 10.1101/gad.943001 Jonkers, 2002, Conditional mouse models of sporadic cancer, Nat. Rev. Cancer, 2, 251, 10.1038/nrc777 Xu, 1999, Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation, Nat. Genet., 22, 37, 10.1038/8743 Jonkers, 2001, Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer, Nat. Genet., 29, 418, 10.1038/ng747 O'Hagan, 2003, Array comparative genome hybridization for tumor classification and gene discovery in mouse models of malignant melanoma, Cancer Res., 63, 5352 Hodgson, 2001, Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas, Nat. Genet., 29, 459, 10.1038/ng771 Uren, 2005, Retroviral insertional mutagenesis: past, present and future, Oncogene, 24, 7656, 10.1038/sj.onc.1209043 Weiss, 2006, The discovery of endogenous retroviruses, Retrovirology, 3, 67, 10.1186/1742-4690-3-67 Mikkers, 2003, Retroviral insertional mutagenesis: tagging cancer pathways, Adv. Cancer Res., 88, 53 Neil, 2002, Retroviral insertion sites and cancer: fountain of all knowledge?, Cancer Cell., 2, 253, 10.1016/S1535-6108(02)00158-7 Clausse, 1993, Activation of both Wnt-1 and Fgf-3 by insertion of mouse mammary tumor virus downstream in the reverse orientation: a reappraisal of the enhancer insertion model, Virology, 194, 157, 10.1006/viro.1993.1245 Selten, 1984, Involvement of c-myc in MuLV-induced T cell lymphomas in mice: frequency and mechanisms of activation, EMBO J., 3, 3215, 10.1002/j.1460-2075.1984.tb02281.x Corcoran, 1984, Murine T lymphomas in which the cellular myc oncogene has been activated by retroviral insertion, Cell, 37, 113, 10.1016/0092-8674(84)90306-4 Akagi, 2004, RTCGD: retroviral tagged cancer gene database, Nucleic Acids Res., 32, D523, 10.1093/nar/gkh013 Gearhart, 2007, Pluripotency redux-advances in stem-cell research, N. Engl. J. Med., 357, 1469, 10.1056/NEJMp078126 Yucel, 2003, The transcriptional repressor Gfi1 affects development of early, uncommitted c-Kit+T cell progenitors and CD4/CD8 lineage decision in the thymus, J. Exp. Med., 197, 831, 10.1084/jem.20021417 Rathinam, 2007, Transcriptional repressor Gfi1 integrates cytokine-receptor signals controlling B-cell differentiation, PLoS ONE, 2, e306, 10.1371/journal.pone.0000306 Mikkers, 2002, High-throughput retroviral tagging to identify components of specific signaling pathways in cancer, Nat. Genet., 32, 153, 10.1038/ng950 Copeland, 1990, Retroviral integration in murine myeloid tumors to identify Evi-1, a novel locus encoding a zinc-finger protein, Adv. Cancer Res., 54, 141, 10.1016/S0065-230X(08)60810-6 Mucenski, 1988, Chromosomal location of Evi-1, a common site of ecotropic viral integration in AKXD murine myeloid tumors, Oncogene Res., 2, 219 Mucenski, 1988, Identification of a common ecotropic viral integration site, Evi-1, in the DNA of AKXD murine myeloid tumors, Mol. Cell Biol., 8, 301, 10.1128/MCB.8.1.301 Wieser, 2007, The oncogene and developmental regulator EVI1: expression, biochemical properties, and biological functions, Gene, 396, 346, 10.1016/j.gene.2007.04.012 Cuypers, 1984, Murine leukemia virus-induced T-cell lymphomagenesis: integration of proviruses in a distinct chromosomal region, Cell, 37, 141, 10.1016/0092-8674(84)90309-X Selten, 1985, Proviral activation of the putative oncogene Pim-1 in MuLV induced T-cell lymphomas, Embo J., 4, 1793, 10.1002/j.1460-2075.1985.tb03852.x van Lohuizen, 1989, Predisposition to lymphomagenesis in pim-1 transgenic mice: cooperation with c-myc and N-myc in murine leukemia virus-induced tumors, Cell, 56, 673, 10.1016/0092-8674(89)90589-8 Dhanasekaran, 2001, Delineation of prognostic biomarkers in prostate cancer, Nature, 412, 822, 10.1038/35090585 Brodeur, 1984, Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage, Science, 224, 1121, 10.1126/science.6719137 Brodeur, 1985, Amplification of N-myc sequences in primary human neuroblastomas: correlation with advanced disease stage, Prog. Clin. Biol. Res., 175, 105 Rosson, 1987, Aberrant splicing events that are induced by proviral integration: implications for myb oncogene activation, Proc. Natl. Acad. Sci. U. S. A., 84, 3171, 10.1073/pnas.84.10.3171 Hoemann, 2000, Two distinct Notch1 mutant alleles are involved in the induction of T-cell leukemia in c-myc transgenic mice, Mol. Cell. Biol., 20, 3831, 10.1128/MCB.20.11.3831-3842.2000 Weng, 2004, Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia, Science, 306, 269, 10.1126/science.1102160 Largaespada, 1996, The neurofibromatosis type 1 (NF1) tumor suppressor gene and myeloid leukemia, Curr. Top. Microbiol. Immunol., 211, 233 Bedigian, 1984, Spontaneous and induced leukemias of myeloid origin in recombinant inbred BXH mice, J. Virol., 51, 586, 10.1128/JVI.51.3.586-594.1984 Suzuki, 2006, Tumor suppressor gene identification using retroviral insertional mutagenesis in Blm-deficient mice, EMBO J., 25, 3422, 10.1038/sj.emboj.7601215 Ellis, 1995, The Bloom's syndrome gene product is homologous to RecQ helicases, Cell, 83, 655, 10.1016/0092-8674(95)90105-1 Luo, 2000, Cancer predisposition caused by elevated mitotic recombination in Bloom mice, Nat. Genet., 26, 424, 10.1038/82548 Wu, 2003, Transcription start regions in the human genome are favored targets for MLV integration, Science, 300, 1749, 10.1126/science.1083413 Touw, 2007, Retroviral insertion mutagenesis in mice as a comparative oncogenomics tool to identify disease genes in human leukemia, Mol. Ther., 15, 13, 10.1038/sj.mt.6300040 Pryciak, 1992, Nucleosomes, DNA-binding proteins, and DNA sequence modulate retroviral integration target site selection, Cell, 69, 769, 10.1016/0092-8674(92)90289-O Muller, 1994, DNA bending creates favored sites for retroviral integration: an explanation for preferred insertion sites in nucleosomes, EMBO J., 13, 4704, 10.1002/j.1460-2075.1994.tb06794.x Mitchell, 2004, Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences, PLoS. Biol., 2, E234, 10.1371/journal.pbio.0020234 Bushman, 2005, Genome-wide analysis of retroviral DNA integration, Nat. Rev. Microbiol., 3, 848, 10.1038/nrmicro1263 Hansen, 2000, Genetic profile of insertion mutations in mouse leukemias and lymphomas, Genome Res., 10, 237, 10.1101/gr.10.2.237 Weiser, 2007, Retroviral insertions in the VISION database identify molecular pathways in mouse lymphoid leukemia and lymphoma, Mamm. Genome, 18, 709, 10.1007/s00335-007-9060-2 Ochman, 1988, Genetic applications of an inverse polymerase chain reaction, Genetics, 120, 621, 10.1093/genetics/120.3.621 Triglia, 1988, A procedure for in vitro amplification of DNA segments that lie outside the boundaries of known sequences, Nucleic Acids Res., 16, 8186, 10.1093/nar/16.16.8186 Riley, 1990, A novel, rapid method for the isolation of terminal sequences from yeast artificial chromosome (YAC) clones, Nucleic Acids Res., 18, 2887, 10.1093/nar/18.10.2887 Devon, 1995, Splinkerettes-improved vectorettes for greater efficiency in PCR walking, Nucleic Acids Res., 23, 1644, 10.1093/nar/23.9.1644 Rothberg, 2008, The development and impact of 454 sequencing, Nat. Biotechnol., 26, 1117, 10.1038/nbt1485 Wheeler, 2008, The complete genome of an individual by massively parallel DNA sequencing, Nature, 452, 872, 10.1038/nature06884 Ning, 2001, SSAHA: a fast search method for large DNA databases, Genome Res., 11, 1725, 10.1101/gr.194201 P. Green, http://www.phrap.org/ (unpublished). Smith, 1981, Identification of common molecular subsequences, J. Mol. Biol., 147, 195, 10.1016/0022-2836(81)90087-5 Gotoh, 1982, An improved algorithm for matching biological sequences, J. Mol. Biol., 162, 705, 10.1016/0022-2836(82)90398-9 Altschul, 1990, Basic local alignment search tool, J. Mol. Biol., 215, 403, 10.1016/S0022-2836(05)80360-2 de Ridder, 2006, Detecting statistically significant common insertion sites in retroviral insertional mutagenesis screens, PLoS Comput. Biol., 2, e166, 10.1371/journal.pcbi.0020166 Suzuki, 2002, New genes involved in cancer identified by retroviral tagging, Nat. Genet., 32, 166, 10.1038/ng949 Wu, 2006, Redefining the common insertion site, Virology, 344, 292, 10.1016/j.virol.2005.08.047 Li, 1999, Leukaemia disease genes: large-scale cloning and pathway predictions, Nat. Genet., 23, 348, 10.1038/15531 Hwang, 2002, Identification of oncogenes collaborating with p27Kip1 loss by insertional mutagenesis and high-throughput insertion site analysis, Proc. Natl. Acad. Sci. U. S. A., 99, 11293, 10.1073/pnas.162356099 Lund, 2002, Genome-wide retroviral insertional tagging of genes involved in cancer in Cdkn2a-deficient mice, Nat. Genet., 32, 160, 10.1038/ng956 Johansson, 2004, Identification of candidate cancer-causing genes in mouse brain tumors by retroviral tagging, Proc. Natl. Acad. Sci. U. S. A., 101, 11334, 10.1073/pnas.0402716101 Theodorou, 2007, MMTV insertional mutagenesis identifies genes, gene families and pathways involved in mammary cancer, Nat. Genet., 39, 759, 10.1038/ng2034 Stewart, 2007, Insertional mutagenesis reveals progression genes and checkpoints in MYC/Runx2 lymphomas, Cancer Res., 67, 5126, 10.1158/0008-5472.CAN-07-0433 Slape, 2007, Retroviral insertional mutagenesis identifies genes that collaborate with NUP98-HOXD13 during leukemic transformation, Cancer Res., 67, 5148, 10.1158/0008-5472.CAN-07-0075 Uren, 2008, Large-scale mutagenesis in p19(ARF)- and p53-deficient mice identifies cancer genes and their collaborative networks, Cell, 133, 727, 10.1016/j.cell.2008.03.021 Nakamura, 1996, Cooperative activation of Hoxa and Pbx1-related genes in murine myeloid leukaemias, Nat. Genet., 12, 149, 10.1038/ng0296-149 Kamps, 1990, A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL, Cell, 60, 547, 10.1016/0092-8674(90)90658-2 Calvo, 2002, Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral co-expression of Hoxa9 and Meis1, Oncogene, 21, 4247, 10.1038/sj.onc.1205516 Lawrence, 1999, Frequent co-expression of the HOXA9 and MEIS1 homeobox genes in human myeloid leukemias, Leukemia, 13, 1993, 10.1038/sj.leu.2401578 Wang, 2006, Persistent transactivation by meis1 replaces hox function in myeloid leukemogenesis models: evidence for co-occupancy of meis1-pbx and hox-pbx complexes on promoters of leukemia-associated genes, Mol. Cell. Biol., 26, 3902, 10.1128/MCB.26.10.3902-3916.2006 de Ridder, 2007, Co-occurrence analysis of insertional mutagenesis data reveals cooperating oncogenes, Bioinformatics, 23, i133, 10.1093/bioinformatics/btm202 Largaespada, 2000, Genetic heterogeneity in acute myeloid leukemia: maximizing information flow from MuLV mutagenesis studies, Leukemia, 14, 1174, 10.1038/sj.leu.2401852 van Lohuizen, 1991, Identification of cooperating oncogenes in E mu-myc transgenic mice by provirus tagging, Cell, 65, 737, 10.1016/0092-8674(91)90382-9 Jacobs, 1999, Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF, Genes Dev., 13, 2678, 10.1101/gad.13.20.2678 van der Lugt, 1995, Proviral tagging in E mu-myc transgenic mice lacking the Pim-1 proto-oncogene leads to compensatory activation of Pim-2, EMBO J., 14, 2536, 10.1002/j.1460-2075.1995.tb07251.x Zippo, 2007, PIM1-dependent phosphorylation of histone H3 at serine 10 is required for MYC-dependent transcriptional activation and oncogenic transformation, Nat. Cell. Biol., 9, 932, 10.1038/ncb1618 Naud, 2007, PIM1 and MYC: a changing relationship?, Nat. Cell. Biol., 9, 873, 10.1038/ncb0807-873 Ellwood-Yen, 2003, Myc-driven murine prostate cancer shares molecular features with human prostate tumors, Cancer Cell., 4, 223, 10.1016/S1535-6108(03)00197-1 Castilla, 2004, Identification of genes that synergize with Cbfb-MYH11 in the pathogenesis of acute myeloid leukemia, Proc. Natl. Acad. Sci. U. S. A., 101, 4924, 10.1073/pnas.0400930101 Yamashita, 2006, Retroviral infection of non-dividing cells: old and new perspectives, Virology, 344, 88, 10.1016/j.virol.2005.09.012 Wang, 2002, Apical barriers to airway epithelial cell gene transfer with amphotropic retroviral vectors, Gene Ther., 9, 922, 10.1038/sj.gt.3301714 Kapitonov, 2008, A universal classification of eukaryotic transposable elements implemented in Repbase, Nat. Rev., Genet., 9, 411, 10.1038/nrg2165-c1 Ivics, 1997, Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells, Cell, 91, 501, 10.1016/S0092-8674(00)80436-5 Collier, 2005, Hopping around the tumor genome: transposons for cancer gene discovery, Cancer Res., 65, 9607, 10.1158/0008-5472.CAN-05-3085 Izsvak, 2000, Sleeping Beauty, a wide host-range transposon vector for genetic transformation in vertebrates, J. Mol. Biol., 302, 93, 10.1006/jmbi.2000.4047 Geurts, 2003, Gene transfer into genomes of human cells by the sleeping beauty transposon system, Mol. Ther., 8, 108, 10.1016/S1525-0016(03)00099-6 Zayed, 2004, Development of hyperactive sleeping beauty transposon vectors by mutational analysis, Mol. Ther., 9, 292, 10.1016/j.ymthe.2003.11.024 Collier, 2005, Cancer gene discovery in solid tumours using transposon-based somatic mutagenesis in the mouse, Nature, 436, 272, 10.1038/nature03681 Dupuy, 2005, Mammalian mutagenesis using a highly mobile somatic Sleeping Beauty transposon system, Nature, 436, 221, 10.1038/nature03691 Collier, 2007, Transposons for cancer gene discovery: Sleeping Beauty and beyond, Genome Biol., 1, S15, 10.1186/gb-2007-8-s1-s15 Dupuy, 2001, Transposition and gene disruption in the male germline of the mouse, Genesis, 30, 82, 10.1002/gene.1037 Yant, 2005, High-resolution genome-wide mapping of transposon integration in mammals, Mol. Cell. Biol., 25, 2085, 10.1128/MCB.25.6.2085-2094.2005 Carlson, 2003, Transposon mutagenesis of the mouse germline, Genetics, 165, 243, 10.1093/genetics/165.1.243 Vigdal, 2002, Common physical properties of DNA affecting target site selection of sleeping beauty and other Tc1/mariner transposable elements, J. Mol. Biol., 323, 441, 10.1016/S0022-2836(02)00991-9 Yusa, 2004, Enhancement of Sleeping Beauty transposition by CpG methylation: possible role of heterochromatin formation, Mol. Cell. Biol., 24, 4004, 10.1128/MCB.24.9.4004-4018.2004 Ikeda, 2007, Sleeping beauty transposase has an affinity for heterochromatin conformation, Mol. Cell. Biol., 27, 1665, 10.1128/MCB.01500-06 Geurts, 2006, Gene mutations and genomic rearrangements in the mouse as a result of transposon mobilization from chromosomal concatemers, PLoS Genet., 2, e156, 10.1371/journal.pgen.0020156 Dupuy, 2006, Sleeping beauty: a novel cancer gene discovery tool, Hum. Mol. Genet., 15, R75, 10.1093/hmg/ddl061 Largaespada, 2008, Transposon-mediated mutagenesis in somatic cells: identification of transposon–genomic DNA junctions, Methods Mol. Biol., 435, 95, 10.1007/978-1-59745-232-8_7 Ding, 2005, Efficient transposition of the piggyBac (PB) transposon in mammalian cells and mice, Cell, 122, 473, 10.1016/j.cell.2005.07.013 Cadinanos, 2007, Generation of an inducible and optimized piggyBac transposon system, Nucleic Acids Res., 35, e87, 10.1093/nar/gkm446 Wilson, 2007, PiggyBac transposon-mediated gene transfer in human cells, Mol. Ther., 15, 139, 10.1038/sj.mt.6300028 Pavlopoulos, 2007, The DNA transposon Minos as a tool for transgenesis and functional genomic analysis in vertebrates and invertebrates, Genome. Biol., 1, S2, 10.1186/gb-2007-8-s1-s2 Zagoraiou, 2001, In vivo transposition of Minos, a Drosophila mobile element, in mammalian tissues, Proc. Natl. Acad. Sci. U. S. A., 98, 11474, 10.1073/pnas.201392398 Drabek, 2003, Transposition of the Drosophila hydei Minos transposon in the mouse germ line, Genomics, 81, 108, 10.1016/S0888-7543(02)00030-7 Moran, 1996, High frequency retrotransposition in cultured mammalian cells, Cell, 87, 917, 10.1016/S0092-8674(00)81998-4 Hohjoh, 1997, Sequence-specific single-strand RNA binding protein encoded by the human LINE-1 retrotransposon, EMBO J., 16, 6034, 10.1093/emboj/16.19.6034 Mathias, 1991, Reverse transcriptase encoded by a human transposable element, Science, 254, 1808, 10.1126/science.1722352 Feng, 1996, Human L1 retrotransposon encodes a conserved endonuclease required for retrotransposition, Cell, 87, 905, 10.1016/S0092-8674(00)81997-2 Lander, 2001, Initial sequencing and analysis of the human genome, Nature, 409, 860, 10.1038/35057062 Babushok, 2006, L1 integration in a transgenic mouse model, Genome Res., 16, 240, 10.1101/gr.4571606 Han, 2004, A highly active synthetic mammalian retrotransposon, Nature, 429, 314, 10.1038/nature02535 Bestor, 2005, Transposons reanimated in mice, Cell, 122, 322, 10.1016/j.cell.2005.07.024 An, 2006, Active retrotransposition by a synthetic L1 element in mice, Proc. Natl. Acad. Sci. U. S. A., 103, 18662, 10.1073/pnas.0605300103 Wardrop, 2005, Identification of two evolutionarily conserved and functional regulatory elements in intron 2 of the human BRCA1 gene, Genomics, 86, 316, 10.1016/j.ygeno.2005.05.006 Gaspar, 2008, Cross-species comparison of human and mouse intestinal polyps reveals conserved mechanisms in adenomatous polyposis coli (APC)-driven tumorigenesis, Am. J. Pathol., 172, 1363, 10.2353/ajpath.2008.070851 Arena, 2007, Knock-in of oncogenic Kras does not transform mouse somatic cells but triggers a transcriptional response that classifies human cancers, Cancer Res., 67, 8468, 10.1158/0008-5472.CAN-07-1126 Schlicht, 2004, Cross-species global and subset gene expression profiling identifies genes involved in prostate cancer response to selenium, BMC Genomics, 5, 58, 10.1186/1471-2164-5-58 Lam, 2006, Conservation of gene expression signatures between zebrafish and human liver tumors and tumor progression, Nat. Biotechnol., 24, 73, 10.1038/nbt1169 Waterston, 2002, Initial sequencing and comparative analysis of the mouse genome, Nature, 420, 520, 10.1038/nature01262 Hackett, 2003, Genome-wide array CGH analysis of murine neuroblastoma reveals distinct genomic aberrations which parallel those in human tumors, Cancer Res., 63, 5266 Cheng, 2007, Cell lines from MYCN transgenic murine tumours reflect the molecular and biological characteristics of human neuroblastoma, Eur. J. Cancer, 43, 1467, 10.1016/j.ejca.2007.03.008 Urzua, 2005, Microarray comparative genomic hybridization profile of a murine model for epithelial ovarian cancer reveals genomic imbalances resembling human ovarian carcinomas, Tumour Biol., 26, 236, 10.1159/000087378 O'Hagan, 2002, Telomere dysfunction provokes regional amplification and deletion in cancer genomes, Cancer Cell, 2, 149, 10.1016/S1535-6108(02)00094-6 Zender, 2006, Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach, Cell, 125, 1253, 10.1016/j.cell.2006.05.030 Kim, 2006, Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene, Cell, 125, 1269, 10.1016/j.cell.2006.06.008 Tomlins, 2006, Of mice and men: cancer gene discovery using comparative oncogenomics, Cancer Cell., 10, 2, 10.1016/j.ccr.2006.06.013 Lee, 2004, Application of comparative functional genomics to identify best-fit mouse models to study human cancer, Nat. Genet., 36, 1306, 10.1038/ng1481 Maser, 2007, Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers, Nature, 447, 966, 10.1038/nature05886 Erkeland, 2006, Significance of murine retroviral mutagenesis for identification of disease genes in human acute myeloid leukemia, Cancer Res., 66, 622, 10.1158/0008-5472.CAN-05-2908 Aguirre, 2004, High-resolution characterization of the pancreatic adenocarcinoma genome, Proc. Natl. Acad. Sci. U. S. A., 101, 9067, 10.1073/pnas.0402932101 Degenhardt, 2008, High-content analysis of cancer genome DNA alterations, Curr. Opin. Genet. Dev., 18, 68, 10.1016/j.gde.2008.01.005 Wendel, 2007, Dissecting eIF4E action in tumorigenesis, Genes Dev., 21, 3232, 10.1101/gad.1604407 Shvarts, 2002, A senescence rescue screen identifies BCL6 as an inhibitor of anti-proliferative p19(ARF)-p53 signaling, Genes Dev., 16, 681, 10.1101/gad.929302 Bussow, 2004, A catalog of human cDNA expression clones and its application to structural genomics, Genome Biol., 5, R71, 10.1186/gb-2004-5-9-r71 Keng, 2009, A conditional transposon-based insertional mutagenesis screen for genes associated with mouse hepatocellular carcinoma, Nat. Biotechnol., 27, 264, 10.1038/nbt.1526 Wiesner, 2009, De novo induction of genetically engineered brain tumors in mice using plasmid DNA, Cancer Res., 69, 431, 10.1158/0008-5472.CAN-08-1800 Su, 2008, A DNA transposon-based approach to validate oncogenic mutations in the mouse, Proc. Natl. Acad. Sci. U. S. A., 105, 19904, 10.1073/pnas.0807785105 Masui, 2005, An efficient system to establish multiple embryonic stem cell lines carrying an inducible expression unit, Nucleic Acids Res., 33, e43, 10.1093/nar/gni043 Steuber-Buchberger, 2008, Simultaneous Cre-mediated conditional knockdown of two genes in mice, Genesis, 46, 144, 10.1002/dvg.20376 Forster, 2005, The invertor knock-in conditional chromosomal translocation mimic, Nat. Methods, 2, 27, 10.1038/nmeth727 Metzler, 2006, A conditional model of MLL-AF4 B-cell tumourigenesis using invertor technology, Oncogene, 25, 3093, 10.1038/sj.onc.1209636 Moffat, 2006, A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen, Cell, 124, 1283, 10.1016/j.cell.2006.01.040 Root, 2006, Genome-scale loss-of-function screening with a lentiviral RNAi library, Nat. Methods, 3, 715, 10.1038/nmeth924 Austin, 2004, The knockout mouse project, Nat. Genet., 36, 921, 10.1038/ng0904-921 Auwerx, 2004, The European dimension for the mouse genome mutagenesis program, Nat. Genet., 36, 925, 10.1038/ng0904-925 Zender, 2008, An oncogenomics-based in vivo RNAi screen identifies tumor suppressors in liver cancer, Cell, 135, 852, 10.1016/j.cell.2008.09.061